In parallel with this finding, we found that UBE2T expression was upregulated in enriched liver CSC populations marked by EpCAM in the publicly available dataset (GSE5975) consisting of 238 HBV-positive HCC clinical specimens, with normal specimens as the control (Fig. 2a). This evidence concerns the gene EPCAM and hepatocellular carcinoma.